Policy

Healthcare stocks suffer amid U.S. debt ceiling debate (Morning Read)

Many healthcare service providers that rely on government reimbursement through Medicare or Medicaid as well as health insurance companies, drugmakers and medical device manufacturers were down on Monday, likely over fears of a fallout surrounding the debt ceiling debates.

Current medical news and unique business news for anyone who cares about healthcare.

Healthcare stocks tumble amid U.S. debt ceiling debate. Many healthcare service providers that rely on government reimbursement through Medicare or Medicaid as well as health insurance companies, drugmakers and medical device manufacturers were down on Monday, likely over fears of a fallout surrounding the debt ceiling debates.

According to the deal passed in the House and awaiting a vote in the Senate, if a bipartisan committee cannot find an additional $1.5 trillion in savings, automatic cuts would begin in 2013 to government programs including Medicare. Here’s the Washington Post’s take on how Medicare and Medicaid will suffer as a result of the debt ceiling debate.

Where are the entry-level health IT jobs? Despite growing use of EMRs in healthcare institutions, the health IT field may not be so job-friendly for college graduates. A recent Hartford Business Journal article looks at the gap in entry-level health IT jobs that’s caused only a handful of Capital Community College’s 2011 health information technology grads to find jobs.

Teva MS oral treatment unsuccessful in study. Teva Pharmaceutical Industries‘ and Active Biotech’s shares suffered after the companies’ experimental oral treatment for multiple sclerosis, laquinimod, failed to reduce the number of relapses in a recent major study. They still plan to file for FDA approval early next year.

Stop the merger! The Independent Specialty Pharmacy Coalition, in addition to others, has called on the FDA to block the Express Scripts-Medco merger announced last month, claiming that it would give the companies more than half of the specialty pharmacy market and greatly reduce competition for smaller companies.

Topics